Risk Communication in Families of Children with Familial Hypercholesterolemia: Identifying Motivators and Barriers to Cascade Screening to Improve Diagnosis at a Single Medical Center

[1]  Emily C. O'Brien,et al.  Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FH™ patient registry. , 2017, Atherosclerosis.

[2]  D. Wald,et al.  Child-Parent Familial Hypercholesterolemia Screening in Primary Care. , 2017, The New England journal of medicine.

[3]  A. Peterson,et al.  Referral Patterns and Cascade Screening for Familial Hypercholesterolemia in a Pediatric Lipid Clinic. , 2016, The Journal of pediatrics.

[4]  D. Wald,et al.  Child-Parent Familial Hypercholesterolemia Screening in Primary Care. , 2016, The New England journal of medicine.

[5]  M. Gulati,et al.  Medication adherence, cascade screening, and lifestyle patterns among women with hypercholesterolemia: Results from the WomenHeart survey. , 2016, Journal of clinical lipidology.

[6]  A. Sturm.  Cardiovascular Cascade Genetic Testing: Exploring the Role of Direct Contact and Technology , 2016, Front. Cardiovasc. Med..

[7]  A. Rodday,et al.  Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES) , 2016, Circulation.

[8]  G. Watts,et al.  Prevalence of Familial Hypercholesterolemia in Adolescents: Potential Value of Universal Screening? , 2016, The Journal of pediatrics.

[9]  Lars H Andersen,et al.  Examining barriers to cascade screening for familial hypercholesterolemia in the United States. , 2016, Journal of clinical lipidology.

[10]  M. Aitken,et al.  Outcomes of a randomised controlled trial of a complex genetic counselling intervention to improve family communication , 2015, European Journal of Human Genetics.

[11]  H. Zierhut,et al.  A novel approach to screening for familial hypercholesterolemia in a large public venue , 2016, Journal of Community Genetics.

[12]  Matthew K Ito,et al.  The Agenda for Familial Hypercholesterolemia: A Scientific Statement From the American Heart Association. , 2015, Circulation.

[13]  J. Kastelein,et al.  Screening and treatment of familial hypercholesterolemia - Lessons from the past and opportunities for the future (based on the Anitschkow Lecture 2014). , 2015, Atherosclerosis.

[14]  R. Santos,et al.  Cascade Screening in Familial Hypercholesterolemia: Advancing Forward. , 2015, Journal of atherosclerosis and thrombosis.

[15]  M. Allison.  Communicating Risk With Relatives in a Familial Hypercholesterolemia Cascade Screening Program: A Summary of the Evidence , 2015, The Journal of cardiovascular nursing.

[16]  G. Watts,et al.  Patients’ Perceptions and Experiences of Familial Hypercholesterolemia, Cascade Genetic Screening and Treatment , 2015, International Journal of Behavioral Medicine.

[17]  S. L. Cox,et al.  Aligning Policy to Promote Cascade Genetic Screening for Prevention and Early Diagnosis of Heritable Diseases , 2015, Journal of Genetic Counseling.

[18]  J. Kastelein,et al.  Ten-year follow-up after initiation of statin therapy in children with familial hypercholesterolemia. , 2014, JAMA.

[19]  Emily C. O'Brien,et al.  Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry. , 2014, American heart journal.

[20]  J. Steinberger,et al.  Implementation of lipid screening guidelines in children by primary pediatric providers. , 2014, The Journal of pediatrics.

[21]  Catherine Boileau,et al.  Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease , 2013, European heart journal.

[22]  M. Porteous,et al.  How do index patients participating in genetic screening programmes for familial hypercholesterolemia (FH) interpret their DNA results? A UK-based qualitative interview study. , 2013, Patient education and counseling.

[23]  D. Simons-Morton,et al.  Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report , 2011, Pediatrics.

[24]  D. Gustafson,et al.  The roles of past behavior and health beliefs in predicting medication adherence to a statin regimen , 2012, Patient preference and adherence.

[25]  G. Watts,et al.  Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. , 2012, The Journal of clinical endocrinology and metabolism.

[26]  T. van der Weijden,et al.  Being at risk for cardiovascular disease: Perceptions and preventive behavior in people with and without a known genetic predisposition , 2012, Psychology, health & medicine.

[27]  D. Wald,et al.  The evaluation of cascade testing for familial hypercholesterolemia , 2012, American journal of medical genetics. Part A.

[28]  地理学.  United States Census Bureau , 2011 .

[29]  S. Daniels.  Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report , 2011, Pediatrics.

[30]  M. Porteous,et al.  Patients' experiences and views of cascade screening for familial hypercholesterolemia (FH): a qualitative study , 2011, Journal of Community Genetics.

[31]  James A. Underberg,et al.  Electronic Chart Review of A Multispecialty Internal Medicine Practice Evaluating Appropriate Identification of Patients with Familial Hyperlipidemia , 2011 .

[32]  J. Defesche.  NLA Symposium on Familial Hypercholesterolemia Defining the challenges of FH Screening for familial hypercholesterolemia , 2010 .

[33]  C. Molster,et al.  Communicating familial hypercholesterolemia genetic information within families. , 2009, Genetic testing and molecular biomarkers.

[34]  S. G. Hadfield,et al.  Family tracing to identify patients with Familial Hypercholesterolaemia: the second Audit of the Department of Health Familial Hypercholesterolaemia Cascade Testing Project , 2009, Annals of clinical biochemistry.

[35]  J. Witteman,et al.  Efficacy of statins in familial hypercholesterolaemia: a long term cohort study , 2008, BMJ : British Medical Journal.

[36]  P. Durrington,et al.  Patients’ Understandings and Experiences of Familial Hypercholesterolemia , 2008, Public Health Genomics.

[37]  D. Amor,et al.  Increased genetic counseling support improves communication of genetic information in families , 2008, Genetics in Medicine.

[38]  P. Atkinson,et al.  Process and outcome in communication of genetic information within families: a systematic review , 2008, European Journal of Human Genetics.

[39]  E. Sijbrands,et al.  Molecular screening for familial hypercholesterolaemia: consequences for life and disability insurance , 2008, European Journal of Human Genetics.

[40]  I. Mesters,et al.  Family communication regarding inherited high cholesterol: why and how do patients disclose genetic risk? , 2007, Social science & medicine.

[41]  Glyn Elwyn,et al.  Process and outcome in communication of genetic information within families: a systematic review , 2007, European Journal of Human Genetics.

[42]  A. Ek,et al.  Disease Knowledge and Adherence to Treatment in Patients With Familial Hypercholesterolemia , 2006, The Journal of cardiovascular nursing.

[43]  G. Suthers,et al.  Letting the family know: balancing ethics and effectiveness when notifying relatives about genetic testing for a familial disorder , 2005, Journal of Medical Genetics.

[44]  S. Humphries,et al.  Cascade testing in familial hypercholesterolaemia: how should family members be contacted? , 2005, European Journal of Human Genetics.

[45]  S. Humphries,et al.  Familial hypercholesterolemia and coronary heart disease: a HuGE association review. , 2004, American journal of epidemiology.

[46]  H. Büller,et al.  Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study , 2004, JAMA.

[47]  G. Bonsel,et al.  How Disturbing Is It to Be Approached for a Genetic Cascade Screening Programme for Familial Hypercholesterolaemia? , 2002, Public Health Genomics.

[48]  L. D. de Villiers,et al.  Prevalence of familial hypercholesterolemia. , 1986, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[49]  J. Verter,et al.  Coronary Artery Disease in 116 Kindred with Familial Type II Hyperlipoproteinemia , 1974, Circulation.

[50]  Norman Louat,et al.  The evaluation of , 1974 .